300 related articles for article (PubMed ID: 28844584)
1. Consistency of psychotropic drug-drug interactions listed in drug monographs.
Liu X; Hatton RC; Zhu Y; Hincapie-Castillo JM; Bussing R; Barnicoat M; Winterstein AG
J Am Pharm Assoc (2003); 2017; 57(6):698-703.e2. PubMed ID: 28844584
[TBL] [Abstract][Full Text] [Related]
2. Quality of Evidence Supporting Major Psychotropic Drug-Drug Interaction Warnings: A Systematic Literature Review.
Nguyen T; Liu X; Abuhashem W; Bussing R; Winterstein AG
Pharmacotherapy; 2020 May; 40(5):455-468. PubMed ID: 32107798
[TBL] [Abstract][Full Text] [Related]
3. Potential drug-drug interactions with psychotropic drugs in paediatric inpatients: A cross-sectional study.
Yalçın N; Özdemir N; Çak Esen HT; Çengel Kültür SE; Demirkan K
Int J Clin Pract; 2021 Jun; 75(6):e14107. PubMed ID: 33624394
[TBL] [Abstract][Full Text] [Related]
4. Drug-Drug Interactions (DDIs) in Psychiatric Practice, Part 8: Relative Receptor Binding Affinity as a Way of Understanding the Differential Pharmacology of Currently Available Antidepressants.
Preskorn SH
J Psychiatr Pract; 2020 Jan; 26(1):46-51. PubMed ID: 31913969
[TBL] [Abstract][Full Text] [Related]
5. Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil.
Castilho ECD; Reis AMM; Borges TL; Siqueira LDC; Miasso AI
J Psychiatr Ment Health Nurs; 2018 Feb; 25(1):3-13. PubMed ID: 28892271
[TBL] [Abstract][Full Text] [Related]
6. Retrospective cohort observation on psychotropic drug-drug interaction and identification utility from 3 databases: Drugs.com®, Lexicomp®, and Epocrates®.
Pinkoh R; Rodsiri R; Wainipitapong S
PLoS One; 2023; 18(6):e0287575. PubMed ID: 37347788
[TBL] [Abstract][Full Text] [Related]
7. Real-world prevalence of potential drug-drug interactions involving oral antineoplastic agents: a population-based study.
Kim SH; Suh Y; Ah YM; Jun K; Lee JY
Support Care Cancer; 2020 Aug; 28(8):3617-3626. PubMed ID: 31802250
[TBL] [Abstract][Full Text] [Related]
8. Drug-Drug Interactions (DDIs) in Psychiatric Practice, Part 2: Strategies to Minimize Adverse Outcomes From Unintended DDIs.
Preskorn SH
J Psychiatr Pract; 2018 Sep; 24(5):341-347. PubMed ID: 30427821
[TBL] [Abstract][Full Text] [Related]
9. Comorbidity, Polytherapy, and Drug Interactions in a Neurological Context: An Example of a Multidisciplinary Approach to Promote the Rational Use of Drugs.
Busa G; Burlina A; Damuzzo V; Chiumente M; Palozzo AC
J Pharm Pract; 2018 Feb; 31(1):58-65. PubMed ID: 29278992
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of frequently used drug interaction screening programs.
Vonbach P; Dubied A; Krähenbühl S; Beer JH
Pharm World Sci; 2008 Aug; 30(4):367-74. PubMed ID: 18415695
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of three drug-drug interaction screening systems against probable clinically relevant drug-drug interactions: a prospective cohort study.
Muhič N; Mrhar A; Brvar M
Eur J Clin Pharmacol; 2017 Jul; 73(7):875-882. PubMed ID: 28299402
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy.
Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C
Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734
[TBL] [Abstract][Full Text] [Related]
13. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
Toivo TM; Mikkola JA; Laine K; Airaksinen M
Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
[TBL] [Abstract][Full Text] [Related]
14. Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States.
Sheikh-Taha M; Asmar M
BMC Geriatr; 2021 Apr; 21(1):233. PubMed ID: 33827442
[TBL] [Abstract][Full Text] [Related]
15. Drug-drug interactions in pediatric oncology patients.
Balk TE; van der Sijs IH; van Gelder T; Janssen JJB; van der Sluis IM; van Leeuwen RWF; Engels FK
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28205376
[TBL] [Abstract][Full Text] [Related]
16. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia.
Wong CM; Ko Y; Chan A
Ann Pharmacother; 2008 Dec; 42(12):1737-48. PubMed ID: 19033481
[TBL] [Abstract][Full Text] [Related]
17. Drug-drug interactions in nursing home residents: analysis from the COME-ON trial.
Lion S; Evrard P; Foulon V; Spinewine A
Age Ageing; 2023 Jan; 52(1):. PubMed ID: 36633299
[TBL] [Abstract][Full Text] [Related]
18. Clinically relevant drug interactions between anticancer drugs and psychotropic agents.
Yap KY; Tay WL; Chui WK; Chan A
Eur J Cancer Care (Engl); 2011 Jan; 20(1):6-32. PubMed ID: 20030690
[TBL] [Abstract][Full Text] [Related]
19. Best practices for documentation of psychotropic drug-drug interactions in an adult psychiatric clinic.
Collins K; Dopheide JA; Wang M; Keshishian T
Ment Health Clin; 2023 Feb; 13(1):11-17. PubMed ID: 36891479
[TBL] [Abstract][Full Text] [Related]
20. Polypharmacy, drug-drug interactions, and adverse drug reactions among systemic sclerosis patients: A cross-sectional risk factor study.
Boukhlal S; Chouchana L; Saadi M; Casadevall M; Cohen P; Dunogue B; Murarasu A; Regent A; Mouthon L; Chaigne B
Semin Arthritis Rheum; 2024 Aug; 67():152469. PubMed ID: 38781783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
